Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) insider Christopher Heery sold 18,168 shares of the business’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $51.33, for a total value of $932,563.44. Following the completion of the sale, the insider now owns 8,938 shares in the company, […]
Arcellx, Inc (NASDAQ:ACLX) Short Interest Up 6 9% in April themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Gilead Sciences (NASDAQ:GILD – Get Free Report) and Mesoblast (NASDAQ:MESO – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, risk, profitability, analyst recommendations, valuation, earnings and dividends. Insider & Institutional Ownership 83.7% of Gilead Sciences shares […]
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.